Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

55.06
Delayed Data
As of 4:00pm ET
 +0.43 / +0.79%
Today’s Change
37.38
Today|||52-Week Range
55.43
+43.35%
Year-to-Date
ABT Regular Dividend: ABT began trading ex-dividend on 10/12/17. A $0.265 dividend will be paid to shareholders of record as of 10/13/17.
5 Must-See Big Cap Earnings Charts
4:42pm / Zacks.com - Paid Partner Content
Phibro Animal Banks on Diverse Portfolio, Competition Rife
10:19am / Zacks.com - Paid Partner Content
Tompkins Financial Corp Buys iShares Core MSCI EAFE, iShares Trust, AbbVie Inc, Sells...
4:38pm / GuruFocus News - Paid Partner Content
Henry Schein (HSIC) Inks Distribution Agreement with Terason
9:41am / Zacks.com - Paid Partner Content
First United Bank Trust Buys Vanguard FTSEEuropean, DowDuPont Inc, iShares Transporta...
11:38am / GuruFocus News - Paid Partner Content
Will PBM Slowdown Hamper Express Scripts (ESRX) Q3 Earnings?
9:30am / Zacks.com - Paid Partner Content
Can Nutrisystem (NTRI) Surprise Investors in Q3 Earnings?
11:08am / Zacks.com - Paid Partner Content
Will Intuitive Surgical (ISRG) Disappoint in Q3 Earnings?
9:30am / Zacks.com - Paid Partner Content
What to Expect From Thermo Fisher (TMO) in Q3 Earnings
10:30am / Zacks.com - Paid Partner Content
Can CR Bard (BCR) Spring a Surprise This Earnings Season?
9:01am / Zacks.com - Paid Partner Content

Today’s Trading

Previous close54.63
Today’s open54.59
Day’s range54.40 - 55.23
Volume5,392,823
Average volume (3 months)5,756,801
Market cap$94.9B
Dividend yield1.93%
Data as of 4:00pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.24%
Earnings growth (next 5 years)+11.30%
Revenue growth (last year)+2.20%
P/E ratio86.0
Price/Sales2.73
Price/Book3.92

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.11+0.13%
NVONovo Nordisk-0.01-0.02%
GSKGlaxoSmithKline-0.03-0.07%
BMYBristol-Myers Squibb+0.53+0.83%
Data as of 4:02pm ET, 10/17/2017

Financials

Next reporting dateOctober 18, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts